Milestone Pharmaceuticals

IPO

With You Every Beat of the Way

Montreal, Canada · Founded 2003 · $125.0M raised

Headquarters
Montreal
Employees
11–50
Founded
2003
Business Model
B2C
Total Funding
$125.0M
Last Round
$125.0M Growth EquityMar 2023
Rounds
4

About

Biopharmaceutical company developing cardiovascular medicines, notably etripamil for paroxysmal supraventricular tachycardia.

Summary

Milestone Pharmaceuticals is a Biotech company based in Montreal, Canada, founded in 2003. It has raised $125.0M in total across 4 rounds, most recently a $125.0M Growth Equity round in Mar 2023. Investors include RTW Investments, Novo Holdings A/S and Forbion Capital Partners.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

IPOJul 2025
$48.7M

Sign up to see all 5 rounds

Series B through IPO — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Milestone Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/milestone-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/milestone-pharmaceuticals" alt="Milestone Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>